|
No |
Age |
Gender |
Duration of disease (yr) |
Duration of skin involvement (yr) |
Type of SSc |
Skin Score |
Lungs |
Serum b-FGF |
Epidermis |
Dermal connective tissue |
Periappendageal /perivascular |
|
1 |
28 |
F |
2 |
1.5 |
L |
2 |
ILD |
nd |
0 |
0 |
0 |
|
2 |
15 |
F |
1 |
1 |
L |
20 |
- |
nd |
++ |
++ |
++ |
|
3 |
21 |
F |
2 |
0.3 |
L |
17 |
ILD |
nd |
+ |
+ |
+ |
|
4 |
25 |
F |
3 |
3 |
D |
42 |
ILD |
nd |
+ |
+ |
0 |
|
5 |
50 |
F |
8 |
6 |
L |
13 |
ILD |
nd |
+ |
++ |
0 |
|
6 |
42 |
F |
1 |
0.5 |
D |
24 |
- |
nd |
++ |
++ |
++ |
|
7 |
24 |
F |
2 |
2 |
D |
16 |
- |
nd |
+ |
++ |
++ |
|
8 |
24 |
F |
3 |
2.6 |
D |
20 |
- |
nd |
+++ |
+++ |
+++ |
|
9 |
24 |
F |
4 |
4 |
D |
8 |
ILD |
nd |
+++ |
+++ |
+++ |
|
10 |
40 |
F |
3 |
3 |
L |
6 |
- |
nd |
++ |
++ |
++ |
|
11 |
40 |
F |
1 |
1 |
D |
32 |
ILD |
nd |
++ |
+ |
0 |
|
12 |
41 |
F |
2.5 |
1.5 |
L |
22 |
ILD |
nd |
0 |
+ |
++ |
|
13 |
42 |
F |
1.5 |
1 |
D |
|
- |
nd |
+ |
+ |
+ |
|
Normal controls |
|
|
|
|
|
|
|
|
|
||
|
1 |
34 |
F |
|
|
|
|
|
|
0 |
0 |
0 |
|
2 |
40 |
F |
|
|
|
|
|
|
0 |
0 |
+ |
|
3 |
28 |
F |
|
|
|
|
|
|
+ |
+ |
++ |
nd not detectable